Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$422K Sell
17,522
-840
-5% -$22K 0.08% 147
2026
Q1
$516K Sell
18,362
-734
-4% -$19.5K 0.11% 135
2025
Q4
$475K Sell
19,096
-1,366
-7% -$34.4K 0.1% 136
2025
Q3
$521K Buy
20,462
+1,165
+6% +$28.8K 0.11% 131
2025
Q2
$468K Sell
19,297
-3,440
-15% -$80.2K 0.11% 137
2025
Q1
$576K Sell
22,737
-39,670
-64% -$1.04M 0.14% 121
2024
Q4
$1.66M Buy
+62,407
New +$1.69M 0.36% 70

Other funds holding PFE

one8zero8 LLC's PFE Position: Q2 2026 in Review

one8zero8 LLC reduced its Pfizer (PFE) stake by 4.6% in Q2 2026, selling an estimated $22K and leaving 17,522 shares worth $422K. The position accounts for 0.08% of the portfolio, ranked #147.

one8zero8 LLC first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.66M in Q4 2024. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • one8zero8 LLC held 17,522 shares of Pfizer worth $422K as of Q2 2026.
  • one8zero8 LLC sold 840 Pfizer shares in Q2 2026, an estimated $22K.
  • Pfizer made up 0.08% of one8zero8 LLC's portfolio in Q2 2026, its #147 holding.
  • one8zero8 LLC first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • one8zero8 LLC's Pfizer position peaked at $1.66M in Q4 2024.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on one8zero8 LLC's 13F filing for Q2 2026, filed 10 Aug 2026.